← Back to All Filings

Vanguard Reports 0% Stake in Medtronic Due to Internal Realignment

Low SignificanceMarch 27, 2026 at 10:31:17 AM EDT

Medtronic plc

$MDTSCHEDULE 13G/ACIK: 0001613103

Subscribe to track MDT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Reports 0% Stake in Medtronic Due to Internal Realignment

Company: Medtronic plc Form: SCHEDULE 13G/A | Filed: 2026/03/27 Significance: Low

Insider: The Vanguard Group Relationship: Institutional Investor

Transaction: • Type: Beneficial Ownership Update • Shares Owned After: 0 • Percent of Class: 0%

Key Insight: The Vanguard Group reports 0 shares owned, but explicitly notes this is due to an internal realignment where subsidiaries now report separately. This is a technical reporting change, not a liquidation of assets.

Market Context: Medtronic has a market cap of $110.62B. This filing represents an administrative change in how Vanguard aggregates its holdings.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Medtronic plc

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Vanguard Group reports 0% ownership due to an administrative realignment of reporting structures, not a market sell-off.
  • Market Impact: Neutral - The filing contains a specific explanatory note regarding the change in beneficial ownership reporting.

Company Information

FieldValue
CompanyMedtronic plc
CIK0001613103
IndustryElectromedical & Electrotherapeutic Apparatus
Market Cap$110.62 Billion

Insider Information

FieldValue
NameThe Vanguard Group
CIK0000102909
RelationshipInstitutional Investor
Previous Status>5% Owner (Implied by 13G/A)

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Event Date03/13/2026
Shares Owned After0
Ownership %0%
Ownership TypeN/A

Financial Impact Assessment

Transaction Materiality

MetricValue
Market Cap$110.62 Billion
Shares Outstanding1,283,880,000
Post-Transaction Ownership0 shares (0% of outstanding)
Materiality AssessmentLow (Administrative)

Impact Evaluation

  • Market Cap Context: While Vanguard is a major holder, this specific filing does not represent a transaction of value against the $110.62B market cap.
  • Ownership Concentration: The filing indicates The Vanguard Group (parent) no longer aggregates ownership for its subsidiaries. The actual underlying shares likely remain held by Vanguard subsidiaries/funds.
  • Transaction Significance: The reduction to 0% is technical. The filing states: "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries."

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a technical compliance filing (Form 13G/A Amendment 10) resulting from corporate restructuring of the filer, not a change in investment thesis or liquidation of the position.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Internal Realignment: The filing explicitly notes that on January 12, 2026, Vanguard underwent a realignment allowing subsidiaries to report beneficial ownership separately (disaggregated basis).
  • Regulatory Basis: The change is made in reliance on SEC Release No. 34-39538.
  • Conclusion: Investors should expect to see separate filings from Vanguard subsidiaries or business divisions in the future, rather than one aggregated total from the parent company.
Topics:#SECFiling#Medtronic#Vanguard#Form13G#InstitutionalOwnership#StockMarket#Investing#FinancialAnalysis#MarketNews

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.